Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Spain

Hospital Universitari Vall d'Hebron, Barcelona